All4Nutra
Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines
The Role of Excipients in Determining Nitrosamine Risks for Drug Products
Simultaneous Determination and Quantification of Nine Nitrosamine Impurities in Semi-Solid Forms Using a GC–MS/MS Method
Optimizing Pharmaceutical Formulations: Strategies for Improving Stability and Minimizing Impurities
Risk Mitigation of Nitrosamines Formation in Drug Products: Role of Excipients – Interview with MEGGLE
Risk Assessment and Management Strategy of Two New Nitrosamine Drug Substance Related Impurities (NDSRIs) in a Pharmaceutical Drug Product for the Treatment of a Rare Disease- from Prediction to Control
